Pyoderma Gangrenosum in an Elderly Woman: Case Report
DOI:
https://doi.org/10.51601/ijhp.v6i1.528Abstract
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly progressive, painful ulcers and may be diagnostically challenging because it mimics infection, vasculitis, and other ulcerative dermatoses. This report describes an 88-year-old Minang woman who presented with multiple enlarging, painful ulcers on both lower legs and thighs over six months, with significant functional limitation requiring wheelchair use. Dermatological examination showed multiple ulcers with granulation to necrotic bases, irregular margins, and undermined edges, with surrounding erythema and hyperpigmentation. Laboratory evaluation demonstrated mild anaemia with otherwise unremarkable results, while Gram staining showed no bacteria. Dermoscopy revealed irregular ulcer borders with yellow-brown crusting on an erythematous background. Histopathology supported ulcerative PG by demonstrating epidermal hyperplasia with acantholysis, inflammatory cell infiltration including polymorphonuclear leukocytes and lymphocytes, mixed dermal infiltrate, and evidence of vascular destruction. The patient was treated with systemic methylprednisolone alongside topical wound care (saline compresses, topical antibiotics, and topical corticosteroids), resulting in reduced pain and lesion improvement at two-week follow-up with no new ulcers. This case highlights the importance of recognising characteristic clinical features, excluding infection, and using histopathology to support diagnosis, particularly in elderly patients where disease burden and complications may be greater and management must prioritise gentle wound care and avoidance of trauma.
Downloads
References
[1] C. Ren, C. Yu, M. Zhang, D. Li, and Y. Zhao, “Treatment of Systemic Sclerosis Complicated with Pyoderma Gangrenosum with Adalimumab: A Case Report of A Rare Disease,” Int. J. Immunopathol. Pharmacol., vol. 38, pp. 1–6, Jan. 2024, doi: 10.1177/03946320241300137.
[2] A. G. Ortega-Loayza et al., “Molecular and Cellular Characterization of Pyoderma Gangrenosum: Implications for the Use of Gene Expression,” J. Invest. Dermatol., vol. 142, no. 4, pp. 1217–1220, Apr. 2022, doi: 10.1016/j.jid.2021.08.431.
[3] D. B. Ghode et al., “Pyoderma Gangrenosum: A Challenging Cutaneous Manifestation in Dubowitz Syndrome,” Cureus, vol. 15, no. 18, p. e43408, Aug. 2023, doi: 10.7759/cureus.43408.
[4] J. Kaler, S. Sheffield, M. Thway, K. Ramsubeik, and G. Kaeley, “Pyoderma Gangrenosum as a Presenting Feature of Undifferentiated Spondyloarthropathy with Erosive Inflammatory Arthritis,” Case Rep. Rheumatol., vol. 2020, pp. 1–7, Mar. 2020, doi: 10.1155/2020/1848562.
[5] S. Lee et al., “Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma Gangrenosum,” JAMA Dermatology, vol. 159, no. 2, p. 151, Feb. 2023, doi: 10.1001/jamadermatol.2022.5437.
[6] H. Shakshouk et al., “Mortality and Autopsy Findings in Patients with Pyoderma Gangrenosum: A Multi-Institutional Series,” Dermatology, vol. 240, no. 2, pp. 352–356, 2024, doi: 10.1159/000536145.
[7] N. Khoshnam-Rad, A. Gheymati, and Z. Jahangard-Rafsanjani, “Tyrosine Kinase Inhibitors-Associated Pyoderma Gangrenosum, A Systematic Review of Published Case Reports,” Anticancer. Drugs, vol. 33, no. 1, pp. 1–8, Jan. 2022, doi: 10.1097/CAD.0000000000001140.
[8] P. Parmar, P. Agarwal, K. Baxi, V. Chaudhary, and R. Chaudhary, “Pustular Pyoderma Gangrenosum with Ulcerative Colitis an Uncommonly Seen Association,” Nepal J. Dermatology, Venereol. Leprol., vol. 22, no. 1, pp. 57–60, 2024, doi: https://doi.org/10.3126/njdvl.v22i1.60728.
[9] E. Shavit et al., “Superficial Granulomatous Pyoderma Gangrenosum Involving the Face : A Case Series of Five Patients and a Review of the Literature,” J. Cutan. Med. Surg., vol. 25, no. 4, pp. 371–376, 2021, doi: 10.1177/1203475420988864.
[10] D. Varghese, C. Ishida, P. Patel, and H. H. Koya, Polypharmacy. StatPearls [Internet]: StatPearls Publishing, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK532953/
[11] S. Dey, N. Sanghavi, A. Wasserman, and K. Kar, “Treatment of Pyoderma Gangrenosum With Mycophenolate and Hyperbaric Oxygen Therapy: A Case Report and Literature Review,” Cureus, vol. 15, no. 4, p. e38159, Apr. 2023, doi: 10.7759/cureus.38159.
[12] N. Abdul Rahman, A. Jazmati, B. Roumi Jamal, I. Darwish, D. Kouja, and S. Ishkhanian, “A Complex Case of PASH Syndrome: Pyoderma Gangrenosum, Acne, Suppurative Hidradenitis, and Crohn’s Disease in A 36-Year-Old Smoker,” Ann. Med. Surg., vol. 86, no. 10, pp. 6280–6284, Oct. 2024, doi: 10.1097/MS9.0000000000002533.
[13] Y. K. Vardhan, “P44 Rapidly Progressive Cutaneous Ulceration in A Toddler,” Rheumatol. Adv. Pract., vol. 6, no. Supplement_1, Sep. 2022, doi: 10.1093/rap/rkac067.044.
[14] K. Kridin, G. Damiani, R. J. Ludwig, D. Tzur Bitan, and A. D. Cohen, “Estimating the Odds of Ulcerative Colitis-Associated Pyoderma Gangrenosum: A Population-Based Case-Control Study,” Dermatology, vol. 237, no. 3, pp. 323–329, 2021, doi: 10.1159/000512931.
[15] E. H. Weiss et al., “Neutrophilic Dermatoses: a Clinical Update,” Curr. Dermatol. Rep., vol. 11, no. 2, pp. 89–102, Mar. 2022, doi: 10.1007/s13671-022-00355-8.
[16] A. Rościszewska, K. Tokarska, A. Kośny, P. Karp, W. Leja, and A. Żebrowska, “The Importance and Challenges of Early Diagnosis of Paraneoplastic Skin Syndromes in Cancer Detection—A Review,” Cancers (Basel)., vol. 17, no. 7, p. 1053, Mar. 2025, doi: 10.3390/cancers17071053.
[17] J. Gomez, E. A. Wang, and K. M. Nord, “Classic Ulcerative Pyoderma Gangrenosum in Fitzpatrick V Skin Type,” Dermatol. Online J., vol. 28, no. 3, pp. 1–2, Jun. 2022, doi: 10.5070/D328357796.
[18] H. Escolà, D. Lopez-Castillo, and R. M. Pojol, “Recurrent Ulcerated Nodules and Erythematous Plaques in A Patient with Kartagener Syndrome,” Clin. Exp. Dermatol., vol. 48, no. 6, pp. 688–690, Jun. 2023, doi: 10.1093/ced/llad055.
[19] M. Barry, A. AlRajhi, and K. Aljerian, “Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult,” Vaccines, vol. 10, no. 1, p. 87, Jan. 2022, doi: 10.3390/vaccines10010087.
[20] D. Croitoru, C. Sibbald, A. Alavi, S. Brooks, and V. Piguet, “Challenging The Association of Hepatitis C and Pyoderma Gangrenosum,” Br. J. Dermatol., vol. 185, no. 5, pp. 1047–1048, Nov. 2021, doi: 10.1111/bjd.20566.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rina Gustia, Hersa Firda Kartika, Mutia Sari

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



















